E-LIB Suche - Ergebnisse für: Zonder, JA

1

A470 Phase II Trial of Mel/Dex + Bortezomib for AL Amyloido..:

Gasparetto, C ; Zonder, JA ; Snyder, R...
Clinical Lymphoma and Myeloma. 9 (2009) - p. S74-S75 , 2009

Link: https://doi.org/10.1016/..

2

Birtamimab plus standard of care in light-chain amyloidosis..:

Gertz, MA ; Cohen, AD ; Comenzo, RL...
https://discovery.ucl.ac.uk/id/eprint/10176359/1/blood.2022019406.pdf. , 2023

Link: https://discovery.ucl.ac..

3

Rates of Influenza and Pneumococcal Vaccination and Correla..:

Thompson, MA ; Boccadoro, M ; Leleu, X...
https://eprints.whiterose.ac.uk/195853/6/Rates%20of%20Influenza%20and%20Pneumococcal%20Vaccination%20and%20Correlation%20With%20Survival%20in%20Multiple%20Myeloma%20Patients.pdf. , 2023

Link: https://eprints.whiteros..

4

Preferences and Priorities for Relapsed Multiple Myeloma Tr..:

Auclair D ; Mansfield C ; Fiala MA...
https://www.dovepress.com/preferences-and-priorities-for-relapsed-multiple-myeloma-treatments-am-peer-reviewed-fulltext-article-PPA. , 2022

Link: https://doaj.org/article..

5

Daratumumab-Based Treatment for Immunoglobulin Light-Chain ..:

Kastritis, E ; Palladini, G ; Minnema, MC...
https://discovery.ucl.ac.uk/id/eprint/10131167/1/nejmoa2028631.pdf. , 2021

Link: https://discovery.ucl.ac..

6

Ixazomib-lenalidomide-dexamethasone in routine clinical pra..:

Hájek, R ; Minařík, J ; Straub, J...
https://eprints.whiterose.ac.uk/173693/6/fon-2020-1225.pdf. , 2021

Link: https://eprints.whiteros..

7

Daratumumab plus CyBorD for patients with newly diagnosed A..:

Palladini, G ; Kastritis, E ; Maurer, MS...
https://discovery.ucl.ac.uk/id/eprint/10095649/1/blood.2019004460.pdf. , 2020

Link: https://discovery.ucl.ac..

8

INSIGHT MM: a large, global, prospective, non-interventiona..:

Costello, C ; Davies, FE ; Cook, G...
https://eprints.whiterose.ac.uk/149400/1/fon-2019-0013_FK.pdf. , 2019

Link: https://eprints.whiteros..

9

Use of carfilzomib in second-line therapy and beyond for re..:

Bhutani D ; Zonder JA
https://www.dovepress.com/use-of-carfilzomib-in-second-line-therapy-and-beyond-for-relapsed-mult-peer-reviewed-article-BLCTT. , 2017

Link: https://doaj.org/article..

10

P-247 Efficacy and safety of linvoseltamab 200 mg in patien..:

Dhodapkar, Madhav ; Bumma, Naresh ; Richter, Joshua...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S172 , 2023

Link: https://doi.org/10.1016/..